维持性血液透析患者血清碱性磷酸酶对心脏病变的评估价值

单婧, 耿燕秋, 刘东, 高卓

武警医学 ›› 2021, Vol. 32 ›› Issue (11) : 925-928.

PDF(665 KB)
PDF(665 KB)
武警医学 ›› 2021, Vol. 32 ›› Issue (11) : 925-928.
论著

维持性血液透析患者血清碱性磷酸酶对心脏病变的评估价值

  • 单婧1, 耿燕秋2, 刘东1, 高卓1
作者信息 +

Evaluation of serum alkaline phosphataseon heart disease in maintenance hemodialysis patients

  • SHAN Jing1, GENG Yanqiu2, LIU Dong1, GAO Zhuo1
Author information +
文章历史 +

摘要

目的 研究维持性血液透析(MHD)患者血清碱性磷酸酶(ALP)对其心脏病变的评估价值。方法 回顾性分析2017-01至2019-10在空军特色医学中心接受规律血液透析治疗的98例患者临床资料,按照患者ALP水平差异将其分为,ALP升高组(>120 U/L)和正常ALP组(≤120 U/L),每组49例。同时化验血清白蛋白(ALB)、血红蛋白(Hb)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)、血清三酰甘油(TG)、血清总胆固醇(TC)、C反应蛋白(CRP)、血钙(Ca)、血磷(P)、全段甲状旁腺激素(iPTH)等指标,完善心脏彩超及颈动脉中膜厚度(intima-media thickness, IMT)检查,比较两组患者相关辅助检查结果,分析上述化验结果对心脏病变的影响。结果 两组患者ALB、Hb、HDL、LDL、TG、TC等指标之间,无统计学差异,两组患者CRP、Ca、P、iPTH、左心室射血分数(LVEF)、舒张早期充盈最大峰值速度/舒张晚期充盈最大峰值速度(E/A)、左房增大、左室扩大、颈动脉斑块发生、心脏瓣膜钙化及颈动脉IMT之间差异有统计学意义(P<0.05)。相关性分析表明,ALP、CRP、P、Ca、颈动脉IMT与心脏病变相关;多因素回归分析显示,ALP水平是心脏病变的独立影响因素(P<0.05)。结论 MHD患者的ALP水平对评估其心脏病变的情况有较高的临床价值。

Abstract

Objective To study the value of serum alkaline phosphatase(ALP) in the assessment of heart disease among maintenance hemodialysis patients. Methods The clinical data on 98 patients who received regular hemodialysis treatment in Air Force Medical Center between January 2017 and October 2019 was retrospectively analyzed. According to ALP levels, the patients were divided into the elevated ALP group (>120 U/L) and normal ALP group (≤120 U/L), with 49 patients in each. Meanwhile, levels of serum albumin (ALB), hemoglobin (HB), high density lipoprotein (HDL), low density lipoprotein (LDL), triglyceride (TG), total cholesterol (TC), C-reactive protein (CRP), blood calcium (CA), blood phosphorus (P), intact parathyroid hormone (iPTH) and other indicators were tested. The cardiac color Doppler ultrasound was used and the carotid artery intima-media thickness was examined. The difference in the results of related auxiliary examinations between the two groups was observed, while the effects of the above test results on cardiac lesions were analyzed. Results There was no significant difference in levels of ALB, HB, HDL, LDL, TG or TC between the two groups (P>0.05). However, there was significant difference in levels of CRP, CA, P, iPTH, LVEF, maximum peak velocity of early diastolic filling/maximum peak velocity of late diastolic filling (E/A), left atrial enlargement, left ventricular enlargement, carotid plaque, cardiac valve calcification and carotid IMT between the two groups (P<0.05). Correlation analysis showed that ALP, CRP, P, Ca and carotid IMT were related to heart disease. Multivariate regression analysis indicated that ALP levels were an independent influencing factor of heart disease (P<0.05). Conclusions Levels of ALP in MHD patients are of high clinical value for assessing the severity of heart disease.

关键词

碱性磷酸酶 / 维持性血液透析 / 颈动脉内膜中层厚度 / 心脏病变

Key words

alkaline phosphatase / maintenance hemodialysis / carotid intima-media thickness / heart disease

引用本文

导出引用
单婧, 耿燕秋, 刘东, 高卓. 维持性血液透析患者血清碱性磷酸酶对心脏病变的评估价值[J]. 武警医学. 2021, 32(11): 925-928
SHAN Jing, GENG Yanqiu, LIU Dong, GAO Zhuo. Evaluation of serum alkaline phosphataseon heart disease in maintenance hemodialysis patients[J]. Medical Journal of the Chinese People Armed Police Forces. 2021, 32(11): 925-928
中图分类号: R541    R692   

参考文献

[1] 王一琳, 李声宏. 颈动脉内中膜厚度与血栓调节蛋白联合检测对血液透析患者并发心血管疾病的预测价值[J].山东医药,2019,59(1): 24-27.
[2] 吴玉芳, 张春容.碱性磷酸酶与冠心病及冠状动脉病变范围的相关性[J]. 广西医学, 2020, 42(6):681-684.
[3] 钟晓芬,林 琳.心脏瓣膜钙化与冠心病发病的关系分析[J].医学理论与实践,2020,33(14):2359-2360.
[4] Fowkes F G, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010:a systematic review and analysis[J].Lancet,2013,382(9901):1329-1340.
[5] 陈爱群,孙 颖, 赵 班, 等. 血成纤维细胞生长因子23水平和颈动脉内中膜厚度对维持性血液透析患者长期预后的影响[J]. 中华老年医学杂志, 2019, 38(7):769-774.
[6] Ha Lahati, Shi JunBao, Yu Haiyi, et al. Association between serum cartilage oligomeric matrix protein andcoronary artery calcification in maintenance hemodialysis patients[J]. J Geriatric Cardiol, 2020,17(2):67-73.
[7] Viecelli A K, O’Lone E, Sautenet B, et al. Vascular access outcomes reported in maintenance hemodialysis trials: a systematic review[J]. Am J Kidney Dis, 2018, 71(3):382-391.
[8] Assimon M M, Brookhart M A, Fine J P, et al. A comparative study of carvedilol versus metoprolol initiation and 1-year mortality among individuals receiving maintenance hemodialysis[J].Am J Kidney Dis, 2018, 72 (3):337-348.
[9] 段玮丽,于彤彤, 宋 佳,等. 血清碱性磷酸酶水平对急性冠状动脉综合征患者预后的影响[J].中国心血管病研究,2019, 17(6): 513-517.
[10] 陈 洁, 陈 妙, 应一樱, 等. 冠状动脉钙化积分对于透析患者心血管事件发生风险的预测价值[J]. 中华全科医学, 2019, 17(11):65-68.
[11] Jamal S A,Hayden J A,Beyene J.Low bone mineral density and fractures inlong-term hemodialysis patients: a meta-analysis[J]. Am J Kidney Dis, 2007, 49 (5):674-681.
[12] Iimori S,Mori Y,Akita W,et al.Diagnostic usefulness of bone mineral densityand biochemical markers of bone turn over in predicting fracture in CKD stage 5Dpatients-a single-center cohort study[J].Nephrol Dial Transplant, 2012, 27(1):345-351.
[13] Ray L, Nanda S K, Chatterjee A, et al. A comparative study of serum aminotransferases in chronic kidney disease with and without end-stage renal disease: need for new reference ranges [J]. Int J Appl Basic Med Res, 2015, 5(1):31-35.
[14] 伍金秋, 钟 清. 血清碱性磷酸酶在慢性肾脏病矿物质和骨代谢紊乱发生发展中作用的研究进展[J]. 山东医药, 2018, 58(21): 102-105.
[15] Krishnamurthy V R, Baird B C, Wei G, et al. Associations of serum alkaline phosphatase with metabolic syndrome and mortality [J]. Am J Med, 2011,124(6):561-566.
[16] Blayney M J, Pisoni R L, Bragg-Gresham J L, et al. High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death [J]. Kidney Int, 2008, 74(5):655-663.
[17] Regidor D L, Kovesdy C P, Mehrotra R, et al. Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients [J]. J Am Soc Nephrol, 2008, 19(11):2193-2203.
[18] Iqbal M P, Mehboobali N, Azam I, et al. Association of alkaline phosphatase with acute myocardial infarction in a population with high prevalence of hypovitaminosis D [J]. Clin Chimica Acta, 2013,425:192-195.
[19] 刘雪姣, 谢晓东, 程 虹, 等.甲状旁腺增生在维持性血液透析患者全因死亡和主要不良心脏事件中的作用[J]. 中国血液净化, 2020, 19(9):592-597.
[20] 佴志慧, 邢 智, 阿丽米拉·赛依提江, 等. 冠心病患者中丙氨酸氨基转移酶与冠状动脉粥样硬化病变程度的相关性分析[J]. 新疆医科大学学报, 2019, 42(3):288-292.
[21] 魏日胞, 龙丽娟, 蔡广研, 等. 老年慢性肾衰病人颈动脉内中膜厚度的变化及其相关因素研究[J]. 解放军医学杂志, 2002, 27(5): 447-449.
[22] Salonen J T, Salonen R. Ultrasonographically assessed carotid morphology and the risk of oronary heart disease[J]. Arterioscler Thromb, 1991,11:1245.
[23] 冯世栋,田秀娟,王 妍,等. 维生素 D 对终末期肾病患者心血管保护研究进展 [J]. 新医学,2018,12(49):863-867.
[24] 刘俊生, 刘 莉, 杨丽娟, 等. 血清iPTH、血浆BNP、NT-proBNP水平在CKD5期患者心功能评价中的应用价值分析[J]. 中华全科医学, 2018, 16(9):1427-1430.
[25] 罗湘凡, 曾 辉, 王英莉, 等.超声检测颈动脉斑块与冠状动脉狭窄发病的关联性研究[J].中国医学装备, 2019, 16(7):102-105.

PDF(665 KB)

Accesses

Citation

Detail

段落导航
相关文章

/